| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.0008 | 1 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.00075 | 1 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.00059 | 1 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.00052 | 1 |